Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VRDN compared with CTMX: revenue, margins and what each company keeps, and the suppliers and customers both name
VRDN
Viridian Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
CTMX
CytomX Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VRDN
Viridian Therapeutics, Inc.
vs
CTMX
CytomX Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VRDN, solid
CTMX, dashed
VRDN
Viridian Therapeutics, Inc.
Change
24.62
▼
−0.20%
Mkt cap
$2.8B
Revenue
$284,000
Q2 FY26
Revenue
$71M
FY25
CTMX
CytomX Therapeutics, Inc.
Change
2.25
▼
−3.91%
Regular session
Sep 2 '83
Mkt cap
$509.9M
Revenue
$1M
Q2 FY26
Revenue
$76M
FY25
vs
Compare
Regular session
Sep 2 '83
VRDN
Viridian Therapeutics, Inc.
vs
CTMX
CytomX Therapeutics, Inc.
24.62
▼
−0.20%
Price
2.25
▼
−3.91%
$2.8B
Mkt cap
$509.9M
Q2 FY26
$284,000
Revenue
$1M
Q2 FY26
FY25
$71M
Revenue
$76M
FY25
Change
Change
VRDN
24.62
▼
−0.20%
vs
CTMX
2.25
▼
−3.91%
Regular session
Sep 2 '83